NewsSouthern Africa’s Cannabis Ambitions

Southern Africa’s Cannabis Ambitions

-

THE Malawi Parliament has backed a bill allowing for the cultivation of cannabis for industrial and medicinal purposes. 

The country is joining a growing list of southern African nations opening their doors to the cannabis industry

Zimbabwe, Lesotho and South Africa all permit medical cannabis and hemp production with the latter decriminalizing the recreational use of cannabis in 2018.

Malawi says the move towards hemp and cannabis will reduce its reliance on on tobacco, which accounts for about 13% of its gross domestic product and 60% of its foreign exchange earnings.

Lesotho has a history of illegal cannabis production stretching back centuries and became the first African country to approve medical pot cultivation in 2017.

Ontario-based Aphria last year launched joint venture with UK extraction company Verve Dynamics. This JV, known as Cann Invest Africa, aims to export Lesotho CBD to global markets. 

Vic Neufeld, CEO of Aphria which prides itself on being a value for money cannabis proposition, said: “Given the abundant natural resources and our collective expertise and that of our partners, Verve is poised to become one of the lowest-cost producers of medical cannabis extracts in the world.” 

A second Canadian cannabis company has beaten a path to Lesotho, with Toronto-based Supreme Cannabis Company investing $10m into Medigrow, giving it a 10% share of the business.

Medigrow was granted permission by the Lesotho government to begin cultivation in 2016 and the partners have entered into a long-term, distribution partnership which will see cannabis oil exported to Canada and elsewhere.

UK medical cannabis firm Eco Equity has started work on a £5m medical cannabis cultivation business in Zimbabwe.

Based in London, it is one of 40 foreign and domestic companies to have secured a licence to grow in the African country since it changed the law last year.

‘The African Cannabis Report’– published by Prohibition Partners, estimated that Africa’s legal Cannabis market could be worth over US$7.1 billion by 2023.



Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

European Cannabis Market Leader Bloomwell Group Secures $10m Investment

The Bloomwell Group has successfully closed a seed funding round of over $10 million dollars—the highest publicly known seed investment...

German Hemp Farm Numbers Up 900% In Seven Years – As industry Calls For Post-Election Reform

THE number of German farms growing industrial hemp has hit 863 – the highest figure since the federal republic...

US Company Set To Launch UK Medical Cannabis Study In Partnership With Manchester University

A GROUND-BREAKING human pilot study centred on the University of Manchester could provide answers to using cannabis as a...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...

You might also likeRELATED
Recommended to you